SCHEMBL7878474

SCHEMBL7878474

O=C1Nc2ccccc2C1=Cc1ccc(O)c2ccccc12

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K7 O43318 1/20 0.72
TAB1 Q15750 1/20 0.72
PLK4 O00444 3/20 0.69
PLK1 P53350 3/20 0.69
RET P07949 3/20 0.66
TDP1 Q9NUW8 1/20 0.66
FLT3 P36888 4/20 0.59
NTRK1 P04629 3/20 0.59
PDGFRB P09619 2/20 0.59
DAPK3 O43293 1/20 0.59
PRKD3 O94806 1/20 0.59
MAP4K4 O95819 1/20 0.59
ABL1 P00519 1/20 0.59
LCK P06239 1/20 0.59
FYN P06241 1/20 0.59
CSF1R P07333 1/20 0.59
PDGFRA P16234 1/20 0.59
LTK P29376 1/20 0.59
GRK5 P34947 1/20 0.59
KDR P35968 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8300232 1.00 MAP3K7 (0.72) MAP3K7TAB1PLK4PLK1RET
SCHEMBL7872417 0.83 MAP3K7 (0.62) MAP3K7TAB1PLK4PLK1RET
SCHEMBL8300100 0.83 MAP3K7 (0.62) MAP3K7TAB1PLK4PLK1RET
SCHEMBL5476218 0.82 PLK4 (1.00) MAP3K7TAB1PLK4PLK1RET
SCHEMBL16442337 0.82 PLK4 (1.00) MAP3K7TAB1PLK4PLK1RET
SCHEMBL5476220 0.82 PLK4 (1.00) MAP3K7TAB1PLK4PLK1RET
SCHEMBL7872431 0.81 MAP3K7 (0.69) MAP3K7TAB1PLK4PLK1RET
SCHEMBL8291297 0.81 MAP3K7 (0.69) MAP3K7TAB1PLK4PLK1RET
SCHEMBL3371607 0.80 PLK4 (0.74) MAP3K7TAB1PLK4PLK1RET
SCHEMBL5472949 0.80 PLK4 (0.74) MAP3K7TAB1PLK4PLK1RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0684820-B1 BIOLOGICALLY ACTIVE 3-SUBSTITUTED OXINDOLE DERIVATIVES USEFUL AS ANTI-ANGIOGENIC AGENTS PHARMACIA & UPJOHN SPA (IT) 2001-08-16 EP claimed
EP-0662473-B1 2-Oxindole derivatives as tyrosine kinase inhibitors PHARMACIA & UPJOHN SPA (IT) 1999-09-01 EP claimed
EP-0662473-A1 2-Oxindole derivatives as tyrosine kinase inhibitors PHARMACIA S.p.A. (IT) 1995-07-12 EP claimed
US-5374652-A Substituted naphthylmethylene- or tetrahydronaphthylmethylene-derivatives of 2-oxoindole FARMITALIA CARLO ERBA S R L (IT) 1994-12-20 US claimed
EP-0470221-A1 NEW ARYL- AND HETEROARYLETHENYLENE DERIVATIVES AND PROCESS FOR THEIR PREPARATION. ERBA CARLO SPA (IT) 1992-02-12 EP claimed
WO-1991013055-A2 NEW ARYL- AND HETEROARYLETHENYLENE DERIVATIVES AND PROCESS FOR THEIR PREPARATION FARMITALIA CARLO ERBA S.R.L. (IT) 1991-09-05 WO claimed
EP-0662473-B1 2-Oxindole derivatives as tyrosine kinase inhibitors PHARMACIA & UPJOHN SPA (IT) 1999-09-01 EP disclosed
US-5627207-A CANCER FARMITALIA CARLO ERBA S R L (IT) 1997-05-06 US disclosed
US-5488057-A ENZYME INHIBITORS AND ANTICARCINOGENIC AGENTS FARMITALIA CARLO ERBA S.R.L. (IT) 1996-01-30 US disclosed
EP-0662473-A1 2-Oxindole derivatives as tyrosine kinase inhibitors PHARMACIA S.p.A. (IT) 1995-07-12 EP disclosed
US-5374652-A Substituted naphthylmethylene- or tetrahydronaphthylmethylene-derivatives of 2-oxoindole FARMITALIA CARLO ERBA S R L (IT) 1994-12-20 US disclosed
WO-1991013055-A2 NEW ARYL- AND HETEROARYLETHENYLENE DERIVATIVES AND PROCESS FOR THEIR PREPARATION FARMITALIA CARLO ERBA S.R.L. (IT) 1991-09-05 WO disclosed